Kirin (OTCMKTS: KNBWY) is one of 54 public companies in the “BEVERAGES” industry, but how does it contrast to its competitors? We will compare Kirin to similar businesses based on the strength of its analyst recommendations, risk, institutional ownership, profitability, valuation, dividends and earnings.
This is a summary of recent recommendations for Kirin and its competitors, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Valuation & Earnings
This table compares Kirin and its competitors top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Kirin||$16.62 billion||$2.16 billion||16.92|
|Kirin Competitors||$7.33 billion||$719.00 million||-2.01|
Kirin has higher revenue and earnings than its competitors. Kirin is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
This table compares Kirin and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Insider and Institutional Ownership
0.2% of Kirin shares are held by institutional investors. Comparatively, 30.8% of shares of all “BEVERAGES” companies are held by institutional investors. 20.7% of shares of all “BEVERAGES” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Volatility and Risk
Kirin has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, Kirin’s competitors have a beta of 0.57, meaning that their average stock price is 43% less volatile than the S&P 500.
Kirin beats its competitors on 6 of the 10 factors compared.
Kirin Company Profile
Kirin Holdings Company, Limited is a holding company. The Company is engaged in alcohol beverages, non-alcohol beverages, and pharmaceuticals and bio-chemicals businesses. The Company’s segments include Integrated Beverages, Pharmaceuticals and Bio-chemicals, and Others. Its Others segment includes food business, such as dairy products, and others. Its businesses comprise Japan Integrated Beverages, Overseas Integrated Beverages, and Pharmaceuticals and Bio-chemicals. The Japan Integrated Beverages business conducts manufacturing and sales of alcoholic beverages and non-alcoholic beverages in Japan. The Overseas Integrated Beverages business includes Lion Nathan Limited (Lion), Schincariol Participacoes e Representacoes S.A. (Brasil Kirin) and Myanmar Brewery Limited. The Pharmaceuticals and Bio-chemicals business includes Kyowa Hakko Kirin Co., Ltd., ProStrakan Group plc and Kyowa Hakko Bio Co., Ltd.
Receive News & Ratings for Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kirin and related companies with MarketBeat.com's FREE daily email newsletter.